List of bibliographic references indexed by prospective
Number of relevant bibliographic references: 15.
| Ident. | Authors (with country if any) | Title |
|---|
| 000185 (2021) |
Sonsoles Salto-Alejandre [Espagne] ; Silvia Jiménez-Jorge [Espagne] ; Nuria Sabé [Espagne] ; Antonio Ramos-Martínez [Espagne] ; Laura Linares [Espagne] ; Maricela Valerio [Espagne] ; Pilar Martín-Dávila [Espagne] ; Mario Fernández-Ruiz [Espagne] ; María Carmen Fari As [Espagne] ; Marino Blanes-Juliá [Espagne] ; Elisa Vidal [Espagne] ; Zaira R. Palacios-Baena [Espagne] ; Román Hernández-Gallego [Espagne] ; Jordi Carratalá [Espagne] ; Jorge Calder N-Parra [Espagne] ; María Ángeles Marcos [Espagne] ; Patricia Mu Oz [Espagne] ; Jesús Fortún-Abete [Espagne] ; José María Aguado [Espagne] ; Francisco Arnaiz-Revillas [Espagne] ; Rosa Blanes-Hernández [Espagne] ; Julián De La Torre-Cisneros [Espagne] ; Luis E. L Pez-Cortés [Espagne] ; Elena García De Vinuesa-Calvo [Espagne] ; Clara M. Rosso [Espagne] ; Jer Nimo Pach N [Espagne] ; Javier Sánchez-Céspedes [Espagne] ; Elisa Cordero [Espagne] | Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study. |
| 000381 (2021) |
Rosa Maria Vivanco-Hidalgo [Espagne] ; Israel Molina [Espagne] ; Elisenda Martinez [Espagne] ; Ram N Roman-Vi As [Espagne] ; Adrián Sánchez-Montalvá [Espagne] ; Joan Fibla [Espagne] ; Caridad Pontes [Espagne] ; César Velasco Mu Oz [Espagne] | Incidence of COVID-19 in patients exposed to chloroquine and hydroxychloroquine: results from a population-based prospective cohort in Catalonia, Spain, 2020. |
| 000648 (2021) |
Dejan Radovanovic [Italie] ; Stefano Pini [Italie] ; Elisa Franceschi [Italie] ; Marica Pecis [Italie] ; Andrea Airoldi [Italie] ; Maurizio Rizzi [Italie] ; Pierachille Santus [Italie] | Characteristics and outcomes in hospitalized COVID-19 patients during the first 28 days of the spring and autumn pandemic waves in Milan: An observational prospective study. |
| 000666 (2021) |
C T Dhanya Raj [Inde] ; Dinesh Kumar Kandaswamy [Inde, Royaume-Uni] ; Ravi Chandra Sekhara Reddy Danduga [Inde] ; Raju Rajasabapathy [Inde] ; Rathinam Arthur James [Inde] | COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics-a review. |
| 000763 (2021) |
Fátima Falcão [Portugal] ; Erica Viegas [Portugal] ; Ines Carmo [Portugal] ; Joana Soares [Portugal] ; Margarida Falcao [Portugal] ; Mariana Solano [Portugal] ; Patricia Cavaco [Portugal] ; Dina Mendes [Portugal] ; João Rijo [Portugal] ; Pedro Povoa [Portugal] ; Antonio Pais Martins [Portugal] ; Eduarda Carmo [Portugal] ; Kamal Mansinho [Portugal] ; Candida Fonseca [Portugal] ; Luis Campos [Portugal] ; Ant Nio Carvalho [Portugal] ; Ana Mirco [Portugal] ; Helena Farinha [Portugal] ; Isabel Aldir [Portugal] ; José Correia [Portugal] | A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report. |
| 000811 (2020) |
Arnaldo Prata-Barbosa [Brésil] ; Fernanda Lima-Setta [Brésil] ; Gustavo Rodrigues Dos Santos [Brésil] ; Vanessa Soares Lanziotti [Brésil] ; Roberta Esteves Vieira De Castro [Brésil] ; Daniela Carla De Souza [Brésil] ; Carlos Eduardo Raymundo [Brésil] ; Felipe Rezende Caino De Oliveira [Brésil] ; Lucio Flavio Peixoto De Lima [Brésil] ; Cristian Tedesco Tonial [Brésil] ; José Colleti [Brésil] ; Ana Paula Novaes Bellinat [Brésil] ; Vivian Botelho Lorenzo [Brésil] ; Raquel De Seixas Zeitel [Brésil] ; Lucas Pulcheri [Brésil] ; Fernanda Ciuffo Monte Da Costa [Brésil] ; Fabíola Peixoto Ferreira La Torre [Brésil] ; Elaine Augusta Das Neves Figueiredo [Brésil] ; Thiago Peres Da Silva [Brésil] ; Paula Marins Riveiro [Brésil] ; Isabele Coelho Fonseca Da Mota [Brésil] ; Igor Bromonschenkel Brandão [Brésil] ; Zina Maria Almeida De Azevedo [Brésil] ; Simone Camera Gregory [Brésil] ; Fernanda Raquel Oliveira Boedo [Brésil] ; Rosana Novais De Carvalho [Brésil] ; Natália Almeida De Arnaldo Silva Rodriguez Castro [Brésil] ; Daniel Hilário Santos Genu [Brésil] ; Flavia Andrea Krepel Foronda [Brésil] ; Antonio José Ledo A. Cunha [Brésil] ; Maria Clara De Magalhães-Barbosa [Brésil] | Pediatric patients with COVID-19 admitted to intensive care units in Brazil: a prospective multicenter study. |
| 000B52 (2020) |
Eoin Feeney [Irlande (pays)] ; Deborah Wallace [Irlande (pays)] ; Aoife Cotter [Irlande (pays)] ; Willard Tinago [Irlande (pays)] ; Cormac Mccarthy [Irlande (pays)] ; David Keane [Irlande (pays)] ; Rabia Hussain [Irlande (pays)] ; Elena Alvarez Barco [Irlande (pays)] ; Peter Doran [Irlande (pays)] ; Patrick Mallon [Irlande (pays)] | The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial. |
| 000B95 (2020) |
Farzaneh Dastan [Iran] ; Seyed Alireza Nadji [Iran] ; Ali Saffaei [Iran] ; Majid Marjani [Iran] ; Afshin Moniri [Iran] ; Hamidreza Jamaati [Iran] ; Seyed Mohammadreza Hashemian [Iran] ; Parvaneh Baghaei [Iran] ; Atefeh Abedini [Iran] ; Mohammad Varahram [Iran] ; Sahar Yousefian [Iran] ; Payam Tabarsi [Iran] | Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. |
| 000C71 (2020) |
Marco Falcone [Italie] ; Giusy Tiseo [Italie] ; Greta Barbieri [Italie] ; Valentina Galfo [Italie] ; Alessandro Russo [Italie] ; Agostino Virdis [Italie] ; Francesco Forfori [Italie] ; Francesco Corradi [Italie] ; Fabio Guarracino [Italie] ; Laura Carrozzi [Italie] ; Alessandro Celi [Italie] ; Massimo Santini [Italie] ; Fabio Monzani [Italie] ; Salvatore De Marco [Italie] ; Mauro Pistello [Italie] ; Romano Danesi [Italie] ; Lorenzo Ghiadoni [Italie] ; Alessio Farcomeni [Italie] ; Francesco Menichetti [Italie] | Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study. |
| 000E30 (2020) |
Ryan W. Stevens [États-Unis] ; Lynn Estes [États-Unis] ; Christina Rivera [États-Unis] | Practical implementation of COVID-19 patient flags into an antimicrobial stewardship program's prospective review. |
| 000F96 (2020) |
Alessandro Capucci ; Andrea Santarelli ; Melchiside Bartolomei ; Corrado Paolizzi ; Carlo Biagetti [Italie] ; Antonella Dappozzo ; Giancarlo Piovaccari | Low hospitalization rate without severe arrhythmias: a prospective survey on 350 patients early home treated with hydroxychloroquine during COVID-19 pandemic. |
| 001352 (2020) |
Antonia Agusti [Espagne] ; Elena Guillen [Espagne] ; Alfonso Ayora [Espagne] ; Andres Anton [Espagne] ; Cristina Aguilera [Espagne] ; Xavier Vidal [Espagne] ; Cristina Andres [Espagne] ; Manuel Alonso [Espagne] ; Meritxell Espuga [Espagne] ; Juliana Esperalba [Espagne] ; M Queralt Gorgas [Espagne] ; Benito Almirante [Espagne] ; Esteban Ribera [Espagne] | Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trial. |
| 001547 (2020) |
Stephane Picot [France] ; Aileen Marty [États-Unis] ; Anne-Lise Bienvenu [France] ; Lucille H. Blumberg [Afrique du Sud] ; Jean Dupouy-Camet [France] ; Pierre Carnevale [France] ; Shigeyuki Kano [Japon] ; Malcolm K. Jones [Australie] ; Cláudio Tadeu Daniel-Ribeiro [Brésil] ; Santiago Mas-Coma [Espagne] | Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19. |
| 001701 (2020) |
Md Jawaid Akhtar [Inde] | COVID19 inhibitors: A prospective therapeutics. |
| 001973 (2020) |
Jonathan Rilinger [Allemagne] ; Winfried V. Kern [Allemagne] ; Daniel Duerschmied [Allemagne] ; Alexander Supady [Allemagne] ; Christoph Bode [Allemagne] ; Dawid L. Staudacher [Allemagne] ; Tobias Wengenmayer [Allemagne] | A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "prospective"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "prospective" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= prospective
}}
| This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021 |  |
